Giant Cell Arteritis - FOI Response Register

1. Does your trust or health board treat giant cell arteritis (GCA)?  If not, please provide the name of the hospital or trust that you refer GCA patients to.

Yes

2. In the past 3 months, how many patients with a primary diagnosis of GCA (ICD10 codes M31.5 or M31.6) were:

Admitted as an inpatient

Nil

Treated in A&E

In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested as patients treated in A&E are not ICD 10 coded.

3. How many patients were treated by the rheumatology department in the past 3 months with the following:

Tocilizumab – for any disease

Tocilizumab for rheumatoid arthritis (RA) only

Tocilizumab for giant cell arteritis (GCA) only

In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested.

4. How many patients were treated by the ophthalmology department (for any disease) in the past 3 months with Tocilizumab?

None

5. How many patients were treated in A&E in the past 3 months for giant cell arteritis (GCA) with Tocilizumab?

In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested as patients treated in A&E are not ICD 10 coded.